PET imaging of GPR44 by Antagonist [11C]MK-7246 in pigs
Cheung P, Zhang B, Puuvuori E, Estrada S, Amin MA, Ye S, Korsgren O, Odell LR, Eriksson J, Eriksson O. 
Biomedicines. 2021;9:434

Longitudinal Assessment of 11 C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes
Espes D, Carlsson PO, Selvaraju RK, Rosestedt M, Cheung P, Ahlström H, Korsgren O, Eriksson O.
Diabetes. 2021;70:966-975

Drug occupancy assessment at the Gastric Inhibitory Polypeptide (GIP) receptor by Positron Emission Tomography
Eriksson O, Velikyan I, Haack T, Bossart M, Evers A, Laitinen I, Larsen PJ, Plettenburg O, Johansson L, Pierrou S, Wagner M. 
Diabetes. 2021;70:842-853.

Imaging of the glucagon receptor in subjects with type 2 diabetes
Eriksson O, Velikyan I, Haack T, Bossart M, Laitinen I, Larsen PJ, Berglund JE, Antoni G, Johansson L, Pierrou S, Tillner J, Wagner M.
J Nucl Med. 2021;62:833-838.

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes mellitus
Eriksson O, Haack T, Hijazzi Y, Teichert L, Tavernier V, Laitinen I, Berglund SE, Antoni G, Velikyan I, Johansson L, Pierrou S, Wagner M, Tillner J. 
Sci Rep. 2020;10:16758.